We are live on ! Find out more
ZCA

Zeke Capital Advisors Portfolio holdings

AUM $1.53B
1-Year Est. Return 17.37%
This Fund
S&P 500
This Quarter Est. Return
-3.9%
1 Year Est. Return
-17.37%
3 Year Est. Return
+41%
5 Year Est. Return
+67.71%
10 Year Est. Return
–
AUM
$1.98B
AUM Growth
+$267M
Cap. Flow
+$333M
Cap. Flow %
16.79%
Top 10 Hldgs %
51.4%
Holding
542
New
227
Increased
158
Reduced
52
Closed
28

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$81.8M
2
MSFT icon
Microsoft
MSFT
+$16.2M
3
AAPL icon
Apple
AAPL
+$12.5M
4
META icon
Meta Platforms (Facebook)
META
+$12.4M
5
CRM icon
Salesforce
CRM
+$12.3M

Top Sells

Rank Stock Value
1
SEAH
Sports Entertainment Acquisition Corp.
SEAH
+$17.4M
2
URGN icon
UroGen Pharma
URGN
+$3.23M
3
PENN icon
PENN Entertainment
PENN
+$3.1M
4
SEAH.WS
Sports Entertainment Acquisition Corp. Redeemable Warrants, each whole Warrant exercisable for one s
SEAH.WS
+$2.27M
5
MTACU
MedTech Acquisition Corporation Unit
MTACU
+$2.01M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 31.38%
2 Communication Services 12.65%
3 Technology 12.58%
4 Real Estate 8.55%
5 Financials 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
76
Alnylam Pharmaceuticals
ALNY
$28.9B
$2.55M 0.13%
15,633
+1,278
+9% +$195K
GDEN
77
DELISTED
Golden Entertainment
GDEN
$2.53M 0.13%
43,602
– –
SGHC.WS
78
DELISTED
Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share
SGHC.WS
$2.52M 0.13%
+875,000
New +$1.53M
WFC icon
79
Wells Fargo
WFC
$265B
$2.5M 0.13%
51,527
+22,402
+77% +$1.2M
MRK icon
80
Merck
MRK
$317B
$2.45M 0.12%
29,821
+14,065
+89% +$1.11M
JPM icon
81
JPMorgan Chase
JPM
$947B
$2.43M 0.12%
17,833
+15,989
+867% +$2.36M
CGBD icon
82
Carlyle Secured Lending
CGBD
$741M
$2.38M 0.12%
165,771
– –
NXPI icon
83
NXP Semiconductors
NXPI
$58.4B
$2.35M 0.12%
12,720
+2,026
+19% +$399K
MCD icon
84
McDonald's
MCD
$196B
$2.35M 0.12%
9,493
+4,401
+86% +$1.1M
VRTX icon
85
Vertex Pharmaceuticals
VRTX
$123B
$2.29M 0.12%
8,762
+1,322
+18% +$314K
PFE icon
86
Pfizer
PFE
$149B
$2.25M 0.11%
43,525
+30,040
+223% +$1.56M
PG icon
87
Procter & Gamble
PG
$342B
$2.21M 0.11%
+14,428
New +$2.26M
IVW icon
88
iShares S&P 500 Growth ETF
IVW
$77B
$2.2M 0.11%
28,860
– –
BRK.A icon
89
Berkshire Hathaway Class A
BRK.A
$1.13T
$2.12M 0.11%
4
– –
C icon
90
Citigroup
C
$224B
$2.11M 0.11%
39,566
+14,379
+57% +$888K
ILMN icon
91
Illumina
ILMN
$29.3B
$2.1M 0.11%
+6,164
New +$2.08M
CVS icon
92
CVS Health
CVS
$123B
$2.07M 0.1%
20,435
+8,871
+77% +$932K
HD icon
93
Home Depot
HD
$349B
$1.92M 0.1%
6,415
+4,613
+256% +$1.6M
MDT icon
94
Medtronic
MDT
$110B
$1.9M 0.1%
17,081
+9,507
+126% +$1M
AIG icon
95
American International
AIG
$42.4B
$1.89M 0.1%
30,127
+1,038
+4% +$62.4K
CVX icon
96
Chevron
CVX
$371B
$1.89M 0.1%
+11,612
New +$1.67M
CRSP icon
97
CRISPR Therapeutics
CRSP
$4.99B
$1.89M 0.1%
30,113
+6,180
+26% +$388K
DOCU
98
DocuSign
DOCU
$10.9B
$1.83M 0.09%
+17,079
New +$1.96M
ABBV icon
99
AbbVie
ABBV
$431B
$1.73M 0.09%
10,692
+9,018
+539% +$1.31M
BIDU icon
100
Baidu
BIDU
$37.1B
$1.73M 0.09%
13,049
+2,232
+21% +$337K
2 3
4
5 6

Similar funds

GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return
S
Seeyond Paris, France $1.03B AUM 9.64% 1-Year Est. Return
LWAC
Laurel Wealth Advisors (California) Solana Beach, California $1.01B AUM 13.55% 1-Year Est. Return
SGA
SB Global Advisers London, United Kingdom $861M AUM 71.72% 1-Year Est. Return
BOTW
Bank of the West Monterey Park, California $851M AUM 15.39% 1-Year Est. Return
PIM
Perpetual Investment Management Sydney, Australia $838M AUM 6.74% 1-Year Est. Return

Zeke Capital Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Zeke Capital Advisors held 542 positions worth $1.98B, up 16% from $1.71B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Zeke Capital Advisors deployed $333M of net new capital in Q1 2022, opening 227 new positions and adding to 158 existing holdings. Its largest new stake was Amazon: 529,280 shares worth $86.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, down from 32% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was UroGen Pharma, an estimated $3.23M trimmed.

  • Zeke Capital Advisors's largest Q1 2022 buy was Amazon: 529,280 shares worth $86.3M.
  • Zeke Capital Advisors added most to Microsoft in Q1 2022, an estimated $16.2M increase.
  • Zeke Capital Advisors's biggest Q1 2022 reduction was UroGen Pharma, cutting an estimated $3.23M.
  • Zeke Capital Advisors fully exited Sports Entertainment Acquisition Corp. in Q1 2022, selling an estimated $17.4M.
  • Zeke Capital Advisors's ten largest holdings make up 51% of its $1.98B portfolio in Q1 2022.
  • Zeke Capital Advisors opened 227 new positions and closed 28 in Q1 2022.
  • Zeke Capital Advisors's portfolio value rose 16% quarter-over-quarter to $1.98B.

Based on Zeke Capital Advisors's 13F filing for Q1 2022, filed 13 May 2022.